Skip to main content

#151534

Pdgfrb-Cre Mouse

Cat. #151534

Pdgfrb-Cre Mouse

Cat. #: 151534

Sub-type: Mouse

Availability: 8-10 weeks

Disease: Cancer

Model: Conditional KO

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Ralf H. Adams

Institute: Cancer Research UK, London Research Institute: Lincoln's Inn Fields

Tool Details
Handling
Target Details
References

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Tool name: Pdgfrb-Cre Mouse
  • Research fields: Cancer;Genetics;Immunology;Tissue-specific biology
  • Tool sub type: Mouse
  • Disease: Cancer
  • Model: Conditional KO
  • Conditional: Yes
  • Conditional description: Pdgfrb-Cre enables conditional, pericyte and smooth vascular muscle cell knockout/knockin/transgene expression of loxP flanked genes.
  • Description: Cre expressed under Pdgfrb promoter enabling conditional recombine expression in pericytes and smooth vascular muscle cells (tissue-specific loxP knockout/knockin)
  • Genetic background: A Pdgfrb-Cre transgene vector, containing a genomic Pdgfrb promoter fragment fused to Cre recombinase and a polyA sequence, was injected into fertilised 129/C57BL6 oocytes. Founder lines were backcrossed to establish transgenic lines on a mixed 129/C57BL6 background.
  • Production details: A Pdgfrb-Cre transgene vector, containing a genomic Pdgfrb promoter fragment fused to Cre recombinase and a polyA sequence, was injected into fertilised 129/C57BL6 oocytes. Founder lines were backcrossed to establish transgenic lines on a mixed 129/C57BL6 background.

Handling

  • Shipping conditions: Embryo/Spermatoza- Dry Ice

Target Details

  • Target: Cre recombinase under Pdgfrb promoter

References

  • Kogata et al. 2009. Genes Dev. 23(19):2278-83. PMID: 19797768.
  • Integrin-linked kinase controls vascular wall formation by negatively regulating Rho/ROCK-mediated vascular smooth muscle cell contraction.
  • Foo et al. 2006. Cell. 124(1):161-73. PMID: 16413489.
  • Ephrin-B2 controls cell motility and adhesion during blood-vessel-wall assembly.

Tool enquiry

Please ensure you use your organisation email address rather than personal where possible, as this helps us locate your organisation in our system faster.

Please note we may take up to three days to respond to your enquiry.

CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.